Dave Stefansky
Chief Executive Officer at Bezalel Capital Partners LLC
Net worth: 624 250 $ as of 30/03/2024
Profile
David Stefansky is the founder of Harborview Capital Management LLC, Harborview Advisors LLC, Kalytera Therapeutics, Inc., and Bezalel Capital Partners LLC, which were founded in 2004, 2004, 2014, and 2013 respectively.
He held the title of Managing Partner at Harborview Capital Management LLC, Principal at Harborview Advisors LLC, and Chairman at Kalytera Therapeutics, Inc. At Bezalel Capital Partners LLC, he is currently the Managing Partner & Principal.
Mr. Stefansky's former jobs include President & Chief Executive Officer at EP Floors, Inc., Chief Executive Officer & Director at chatAND, Inc., President & Chief Executive Officer at NewCardio, Inc., Chairman at HepaLife Technologies, Inc., Chairman at Gondwana Gold, Inc., Chairman at Claritas Pharmaceuticals, Inc., Managing Director-Investment Banking at vFinance, Inc., Director at Mobile Reach International, Inc., Director at Boxwoods, Inc., Director at Mill Basin Technologies, Ltd., Director at Marine Park Holdings, Inc., Independent Director at NexGel, Inc., Director at Alliqua BioMedical, Inc., Director at Ehave, Inc., and Principal at Bezalel Partners LLC.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEXGEL, INC.
3.69% | 16/08/2023 | 228,663 ( 3.69% ) | 624 250 $ | 30/03/2024 |
Dave Stefansky active positions
| Companies | Position | Start |
|---|---|---|
| Bezalel Capital Partners LLC | Chief Executive Officer | 31/12/2012 |
Former positions of Dave Stefansky
| Companies | Position | End |
|---|---|---|
| NEXGEL, INC. | Director/Board Member | 30/12/2023 |
| CLARITAS PHARMACEUTICALS, INC. | Chairman | 25/05/2017 |
| EHAVE, INC. | Director/Board Member | 16/01/2017 |
| CHATAND, INC. | Chief Executive Officer | 02/01/2017 |
Alliqua BioMedical, Inc.
 Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Chairman | 28/11/2012 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| NEWCARDIO, INC. | Health Technology |
| NEXGEL, INC. | Process Industries |
| EHAVE, INC. | Technology Services |
| CLARITAS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 17 |
|---|---|
vFinance, Inc.
 vFinance, Inc. Investment Banks/BrokersFinance vFinance, Inc. provides financial services. It offers institutional brokerage and investment banking services to the professional traders, hedge funds, and other institutional clients. The company was founded by Leonard Jay Sokolow and Timothy Mahoney in February 1992 and is headquartered in Boca Raton, FL. | Finance |
| Mobile Reach International, Inc. | Technology Services |
HepaLife Technologies, Inc.
 HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Health Services |
Boxwoods, Inc.
 Boxwoods, Inc. Financial ConglomeratesFinance The Company is currently an inactive company seeking merger and business operations opportunities. On 27-Oct-2006, the Company ceased operations, and discontinued all business activities. | Finance |
| EP Floors, Inc. | Industrial Services |
HG Partners, Inc.
 HG Partners, Inc. Financial ConglomeratesFinance HG Partners, Inc. provides commercial and residential installation and maintenance (HVAC) services in the heating, ventilation, and air conditioning industry. The company was founded in January 2006 and is headquartered in Pearland, TX. | Finance |
Gondwana Gold, Inc.
 Gondwana Gold, Inc. Precious MetalsNon-Energy Minerals Gondwana Gold, Inc. is a junior mineral exploration company engaged in the acquisition, exploration and development of properties for the mining of gold and other economic deposits. The company's exploration properties are located in West Africa. Gondwana Gold was founded on July 24, 2007 and is headquartered in Toronto, Canada. | Non-Energy Minerals |
chatAND, Inc.
 chatAND, Inc. Packaged SoftwareTechnology Services chatAND, Inc. provides online assistance, engagement and conversion solutions to eCommerce businesses. It allows real-time assistance to website visitors utilizing video conferencing, screen sharing and collaborative co-browsing to increase sales conversion rates. The company was founded by Michael Lebor and David Rosenberg on May 14, 2010 and is headquartered in New York, NY. | Technology Services |
| Mill Basin Technologies, Ltd. | Finance |
| Marine Park Holdings, Inc. | Finance |
Harborview Capital Management LLC
 Harborview Capital Management LLC Investment ManagersFinance Harborview Capital Management LLC (Harborview) is an independent hedge fund manager headquartered in New York City. The firm was founded by David “Dave” Stefansky in 2004. Harborview manages the assets of high-net-worth clients. | Finance |
| NewCardio, Inc. /Old/ | Health Technology |
Harborview Advisors LLC
 Harborview Advisors LLC Investment ManagersFinance Part of Harborview Investments LLC, Harborview Advisors LLC is a wealth management company based in Portland, ME. Harborview Advisors offers financial planning and portfolio management services to help clients achieve their investment goals. The private company's team of experienced finance professionals provides unbiased recommendations and impartial guidance to clients. Harborview Advisors' approach involves clarifying their fee structure, analyzing clients' goals, and recommending an investment strategy designed to meet their risk tolerance. The company's website also offers a form to get started on an investment plan and a downloadable form CRS. The company was founded in 2004 by David Stefansky. | Finance |
Kalytera Therapeutics, Inc. /Old/
 Kalytera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Kalytera Therapeutics, Inc. develops non-psychoactive cannabinoid and endocannabinoid-like medicines that address the large unmet market needs. Its preclinical studies support the continued investigation of Kalytera drug candidates in a range of conditions, including bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan and David Stefansky in 2014 and is headquartered in Manhattan Beach, CA. | Health Technology |
Bezalel Partners LLC
 Bezalel Partners LLC Financial ConglomeratesFinance Bezalel Partners LLC provides investment services. The private company is based in Franklin, TN. | Finance |
| Bezalel Capital Partners LLC | |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Health Technology |
- Stock Market
- Insiders
- Dave Stefansky
